Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

LIV Golf has found a global media partner. The Saudi-funded renegade golf league has reached a deal with sports streaming giant DAZN that will see LIV Golf air for free in over 200 global markets.

PONTE VEDRA BEACH, Fla. -- PGA Tour commissioner Jay Monahan did his best to fend off questions regarding the organization's ongoing negotiations with LIV Golf's financial backers, Saudi Arabia's ...

You can get in touch with Devlina by emailing [email protected]. A few weeks ago, it seemed possible that LIV golfers like Sergio Garcia, Bryson DeChambeau, and Brooks Koepka might have a ...

For the last three years that Justin Thomas has stepped onto the interview podium at the Players Championship there has been one constant: the topic of LIV, the PGA Tour and their ongoing battle.

PONTE VEDRA BEACH, Fla. — Has LIV Golf pushed the PGA Tour to get better? For the first time since the onset of the disruptor league, PGA Tour commissioner Jay Monahan acknowledged that its ...

Golf’s burning question for more than 18 months has been about reunification. And a part of that reunification is whether LIV players will be allowed back on the PGA Tour. If they are, what would that ...

That negative investor reaction was directed at companies involved in the white-hot weight loss drug segment of the market (Eli Lilly is the pharmaceutical giant behind a popular one, Zepbound).

It's very much my pleasure to welcome members of Lilly's leadership team to be here with us in Miami, and thank you for making the trip. So, to my right is Lucas Montarce who is the company's CFO ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide. “We feel that a product like an oral, orforglipron, could serve a significant ...

March 10 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and Mexico in the second half of ...